Latest from Shefali Luthra
-
Republicans in North Carolina override veto of 12-week abortion ban
The ban's time limit and new restrictions will functionally eliminate one of the South's last abortion destinations.
-
Three GOP-led states are set to vote on new abortion bans today
If passed, the new bans — 12-week prohibitions in North Carolina and Nebraska, and a six-week ban in South Carolina — could further erode access to care.
-
Abortion bans are unpopular. Republicans are passing them anyway.
In some cases, anti-abortion legislators have been forced to backtrack from some more restrictive proposals. In others, they’ve tried to subvert the lawmaking process to avoid blowback.
-
Birth control is one step closer to being available over the counter
If implemented, the move by the FDA could expand access to a key method of contraception without a prescription and with no age restrictions.
-
How we told the story of the summer Roe v. Wade fell
Health reporter Shefali Luthra reflects on how America lost Roe v. Wade in the summer of 2022 and how The 19th was able to tell that story.
-
North Carolina passes 12-week abortion ban
The abortion ban, which now goes to the governor, could severely curtail already limited access in the South. And if they all vote together, Republicans could override a veto.
-
93 days: The summer America lost Roe v. Wade
Twelve Americans — patients, doctors, politicians, activists — relived the uncertainty and chaos of losing federal abortion protections. This oral history chronicles their stories.
-
Supreme Court temporarily blocks mifepristone restrictions in a rare win for abortion rights
The decision, issued Friday, delays a ruling from a federal appeals court and will allow abortion providers to continue providing the drug as usual for now.
-
If mifepristone is blocked, access to medication abortion pills could vary by state — or even by clinic
Faced with a complex risk calculus, some clinics will continue offering mifepristone they have stockpiled, while others are preparing to drop medication abortion altogether.
-
Federal judges issue conflicting rulings in a pill used for medication abortion
A federal judge in Texas blocked the FDA's approval of mifepristone. Another in Washington state issued a conflicting ruling. The matter now seems poised to head for the Supreme Court.